SDC4

Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan co · P31431 · SDC4 on Sugi Atlas →

2,226 patent compounds predicted against SDC4, 2,147 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Brigatinib Brigatinib (SCHEMBL11916361) 1.00 1/20
SCHEMBL11916482 SCHEMBL11916482 0.94 1/20
SCHEMBL11916444 SCHEMBL11916444 0.94 1/20
SCHEMBL11916541 SCHEMBL11916541 0.93 1/20
SCHEMBL15207624 SCHEMBL15207624 0.89 1/20
SCHEMBL11916537 SCHEMBL11916537 0.88 1/20
SCHEMBL15217787 SCHEMBL15217787 0.88 1/20
SCHEMBL11916582 SCHEMBL11916582 0.88 1/20
SCHEMBL11916511 SCHEMBL11916511 0.88 1/20
SCHEMBL11916532 SCHEMBL11916532 0.88 1/20
SCHEMBL11916644 SCHEMBL11916644 0.87 1/20
SCHEMBL11916520 SCHEMBL11916520 0.87 1/20
SCHEMBL11916443 SCHEMBL11916443 0.87 1/20
SCHEMBL11916485 SCHEMBL11916485 0.86 1/20
SCHEMBL15217786 SCHEMBL15217786 0.86 1/20
SCHEMBL11916418 SCHEMBL11916418 0.85 1/20
SCHEMBL11916453 SCHEMBL11916453 0.85 1/20
SCHEMBL11916461 SCHEMBL11916461 0.85 1/20
SCHEMBL11916474 SCHEMBL11916474 0.85 1/20
SCHEMBL11916431 SCHEMBL11916431 0.85 1/20

Clinical trials — most relevant to SDC4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Dexmedetomidine and Total Intravenous Anesthesia on Endothelial Damage-Related Biomarkers PHASE4COMPLETED
Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation PHASE4ACTIVE_NOT_RECRUITING
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Study of Protection And Repair of Endothelial-glycocalyx in Sepsis (SPARES) PHASE2NOT_YET_RECRUITING
Syndecan-1 a Surrogate Marker for IBD nanCOMPLETED
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1 nanUNKNOWN
Syndecan-4 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients nanRECRUITING
Myoglobin Removal With CytoSorb in Rhabdomyolysis nanCOMPLETED
Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With Periodontal Health and Stage III Periodontitis, Considering Both Smokers and Non-Smokers, Before and After Non-Surgical Periodontal Therapy nanACTIVE_NOT_RECRUITING
Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT nanCOMPLETED
VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation nanUNKNOWN
The Glycocalyx in COVID-19 Patients. A Pilot Study nanCOMPLETED
Perioperative Plasma Levels of Glycocalyx Markers in Colon Surgery. nanUNKNOWN
COronary Microcirculation and Troponin Elevation in Septic Shock nanCOMPLETED
Alpha-lipoic Acid in Critically Ill Patients With Sepsis nanCOMPLETED
The FGF/FGFR Signalling Pathway: nanCOMPLETED
Comparison of the Effects of Sevoflurane and Desflurane on Endothelial Glycocalyx nanCOMPLETED
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation nanCOMPLETED
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches nanUNKNOWN
Cardiogenic Shock Integrated PHenotyping for Event Reduction nanRECRUITING
Comparison of Liberal and Restrictive Fluid Management on the Endothelial Glycocalyx in Radical Cystectomy nanCOMPLETED
The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery nanCOMPLETED
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer nanACTIVE_NOT_RECRUITING
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests nanUNKNOWN
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy nanRECRUITING
Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient nanRECRUITING
Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis nanCOMPLETED
Mechanisms of Diabetic Nephropathy in Ecuador nanSUSPENDED
Gene First Approach to Connective Tissue Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SDC4 binder may also engage these)

ProteinNameSimilarity
Q5RAT9 1.000 Q5RAT9 →
P34901 1.000 P34901 →
Q8HZJ6 1.000 Q8HZJ6 →
P34900 0.999 P34900 →
Q6GR51 0.999 Q6GR51 →
Q58DD4 0.998 Q58DD4 →
O35988 0.997 O35988 →
P43407 0.996 P43407 →
SDC2 Syndecan-2 0.996 landscape →
P49414 0.993 P49414 →
P49416 0.992 P49416 →
Q1AGV6 0.991 Q1AGV6 →
P50605 0.990 P50605 →
B1H3G4 0.987 B1H3G4 →
Q5RE35 0.987 Q5RE35 →
P31955 0.987 P31955 →
Q9BZD6 0.986 Q9BZD6 →
Q95M19 0.986 Q95M19 →
A1A4K1 0.986 A1A4K1 →
Q56A20 0.986 Q56A20 →
P10909 0.986 P10909 →
Q96FE7 0.986 Q96FE7 →
Q9Y5Y7 0.986 Q9Y5Y7 →
P14221 0.986 P14221 →
Q7TMJ8 0.986 Q7TMJ8 →
Q9VPN2 0.985 Q9VPN2 →
Q14CH0 0.985 Q14CH0 →
Q6P995 0.985 Q6P995 →
Q8BGN6 0.985 Q8BGN6 →
P58239 0.984 P58239 →